
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 4 389-396, Copyright © 1993 by American Association for Cancer Research
ARTICLES |
GE Goodman, GS Omenn, MD Thornquist, B Lund, B Metch and I Gylys-Colwell
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
In preparation for a phase IV lung cancer chemoprevention trial, we conducted a pilot trial of beta-carotene and retinol in high-risk smokers. Eligibility criteria were ages of 50-69 years, a smoking history of at least 20 pack-years, and either being a current smoker or having quit within the past 6 years. Participants were recruited by mailing an interest survey to 29,928 age-selected members of King County Medical Blue Shield. We randomized 1,029 women and men to one of four intervention arms: placebo, retinol, 25,000 international units/day; beta-carotene, 30 mg/day; or retinol plus beta-carotene. Participants were followed for side effects and adherence every 2 months either by a telephone call or a clinic visit. Blood was sampled for retinoid, carotenoid, and liver function analyses annually. beta-carotene and retinol were well tolerated during the follow-up period, which had a median of 1.5 years and a maximum of 3.3 years. Yellowing of the skin was seen in both beta-carotene arms. No differences were seen among arms or over time in incidence or severity of the other 15 monitored symptoms and signs or in serum liver function tests. Adherence was good: 83% of participants remained active on study at 1 year and 75% at 2 years. Serum beta-carotene increased from a prerandomization median concentration of 170 to 2100 ng/ml after 4 months of supplementation, and retinyl palmitate median levels more than tripled.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
C. Persson, S. Sasazuki, M. Inoue, N. Kurahashi, M. Iwasaki, T. Miura, W. Ye, S. Tsugane, and for the JPHC Study Group Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study Carcinogenesis, May 1, 2008; 29(5): 1042 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito Dietary supplements in patients with cancer: Risks and key concepts, part 1 Am. J. Health Syst. Pharm., February 15, 2007; 64(4): 369 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Aliyu, M. R. Cullen, M. J. Barnett, J. R. Balmes, B. Cartmel, C. A. Redlich, C. A. Brodkin, S. Barnhart, L. Rosenstock, L. Israel, et al. Evidence for Excess Colorectal Cancer Incidence among Asbestos-exposed Men in the Beta-Carotene and Retinol Efficacy Trial Am. J. Epidemiol., November 1, 2005; 162(9): 868 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Cullen, M. J. Barnett, J. R. Balmes, B. Cartmel, C. A. Redlich, C. A. Brodkin, S. Barnhart, L. Rosenstock, G. E. Goodman, S. P. Hammar, et al. Predictors of Lung Cancer among Asbestos-exposed Men in the {beta}-Carotene and Retinol Efficacy Trial Am. J. Epidemiol., February 1, 2005; 161(3): 260 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Alfano, R. C. Klesges, D. M. Murray, D. J. Bowen, A. McTiernan, M. W. Vander Weg, L. A. Robinson, B. Cartmel, M. D. Thornquist, M. Barnett, et al. Physical Activity in Relation to All-Site and Lung Cancer Incidence and Mortality in Current and Former Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2233 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kakizoe Chemoprevention of Cancer - Focusing on Clinical Trials Jpn. J. Clin. Oncol., September 1, 2003; 33(9): 421 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ballew, B. A Bowman, R. M Russell, A. L Sowell, and C. Gillespie Serum retinyl esters are not associated with biochemical markers of liver dysfunction in adult participants in the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Am. J. Clinical Nutrition, May 1, 2001; 73(5): 934 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cartmel, T. E Moon, and N. Levine Effects of long-term intake of retinol on selected clinical and laboratory indexes Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H. Williams, et al. Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease N. Engl. J. Med., May 2, 1996; 334(18): 1150 - 1155. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |